12.68

0.94% -0.12

Wave Life Sciences Ltd (WVE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WVE Giù? Forum Previsione

Precedente Chiudi:

$12.80

Aprire:

$13.16

Volume 24 ore:

2.10M

Relative Volume:

0.32

Capitalizzazione di mercato:

$2.36B

Reddito:

$93.95M

Utile/perdita netta:

$-129.87M

Rapporto P/E:

-14.09

EPS:

-0.9

Flusso di cassa netto:

$-202.88M

1 W Prestazione:

-5.72%

1M Prestazione:

-10.83%

6M Prestazione:

+44.75%

1 anno Prestazione:

+17.41%

Intervallo 1D:

$12.54

$13.16

Intervallo di 1 settimana:

$12.51

$14.15

Portata 52W:

$5.28

$21.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Nome

Wave Life Sciences Ltd

Settore

Healthcare (1111)

Industria

Biotechnology (622)

Telefono

617-949-2900

Indirizzo

7 STRAITS VIEW, SINGAPORE

Dipendente

288

Cinguettio

@WAVELifeSci

Prossima data di guadagno

2025-03-04

Ultimi documenti SEC

WVE's Discussions on Twitter

Compare WVE vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WVE Wave Life Sciences Ltd	12.68	2.38B	93.95M	-129.87M	-202.88M	-0.90
VRTX Vertex Pharmaceuticals Inc	491.47	117.98B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	803.17	82.85B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	821.96	51.58B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	314.40	40.75B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.07	38.33B	4.98B	69.60M	525.67M	0.5198

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-05	Iniziato	BofA Securities	Buy
2025-12-12	Reiterato	Wedbush	Outperform
2025-12-09	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2025-10-20	Iniziato	Wells Fargo	Overweight
2025-08-04	Iniziato	Canaccord Genuity	Buy
2025-07-28	Iniziato	Oppenheimer	Outperform
2025-07-16	Iniziato	Citigroup	Buy
2025-06-11	Ripresa	Raymond James	Outperform
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2025-04-08	Iniziato	Wedbush	Outperform
2025-02-25	Iniziato	Jefferies	Buy
2024-10-16	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-09-27	Ripresa	JP Morgan	Overweight
2024-09-19	Iniziato	B. Riley Securities	Buy
2024-09-09	Iniziato	JP Morgan	Overweight
2024-05-15	Iniziato	Wells Fargo	Overweight
2023-12-19	Aggiornamento	Leerink Partners	Market Perform → Outperform
2023-07-05	Iniziato	Raymond James	Outperform
2023-05-24	Downgrade	Jefferies	Buy → Hold
2020-12-15	Ripresa	H.C. Wainwright	Buy
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2019-12-31	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-11-01	Iniziato	Guggenheim	Buy
2019-07-15	Iniziato	Cowen	Market Perform
2019-04-17	Reiterato	H.C. Wainwright	Buy
2018-08-07	Iniziato	Stifel	Buy
2018-07-23	Iniziato	H.C. Wainwright	Buy
2018-03-19	Reiterato	Mizuho	Buy
2017-02-15	Iniziato	H.C. Wainwright	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-12-07	Iniziato	JMP Securities	Mkt Outperform
2015-12-07	Iniziato	Jefferies	Buy
2015-12-07	Iniziato	Leerink Partners	Outperform
2015-12-07	Iniziato	Sun Trust Rbsn Humphrey	Buy

Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

Feb 13, 2026

Can Wave Life Sciences Ltd. stock deliver surprise earnings beatJuly 2025 Institutional & Entry Point Confirmation Signals - mfd.ru

Feb 13, 2026

Feb 12, 2026

WAVE Life Sciences (NASDAQ:WVE) Given New $27.00 Price Target at Wells Fargo & Company - MarketBeat

Feb 12, 2026

WVE Stock Update: Wells Fargo Adjusts Price Target Amidst Steady - GuruFocus

Feb 12, 2026

Feb 11, 2026

Paul Bolno Sells 10,480 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat

Feb 11, 2026

Insider Selling: WAVE Life Sciences (NASDAQ:WVE) Insider Sells 1,883 Shares of Stock - MarketBeat

Feb 11, 2026

Kyle Moran Sells 3,588 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat

Feb 11, 2026

Is Wave Life Sciences Ltd. stock supported by strong cash flowsJuly 2025 Recap & Technical Pattern Recognition Alerts - mfd.ru

Feb 11, 2026

(02/11/26) Top Picks 2026: Wave Life Sciences Ltd. (WVE) - moneyshow.com

Feb 11, 2026

Feb 09, 2026

Published on: 2026-02-10 01:59:11 - baoquankhu1.vn

Feb 09, 2026

Wave Life Sciences (WVE) regains rights to potential rare genetic disorder treatment - MSN

Feb 09, 2026

Feb 08, 2026

The Bull Case For Wave Life Sciences (WVE) Could Change Following WVE-006 Rights Reversion And FDA Talks - Yahoo Finance

Feb 08, 2026

Assessing Wave Life Sciences (WVE) Valuation After A 7x Three Year Total Return - Yahoo Finance

Feb 08, 2026

Why The Wave Life Sciences WVE Story Is Shifting After New RNA And AATD Updates - Yahoo Finance

Feb 08, 2026

Feb 07, 2026

Will Regaining Full Rights to WVE-006 and Pursuing FDA Fast Track Change Wave Life Sciences' (WVE) Narrative - simplywall.st

Feb 07, 2026

How (WVE) Movements Inform Risk Allocation Models - Stock Traders Daily

Feb 07, 2026

Wave Life Sciences (WVE) Regains Rights to Potential Rare Genetic Disorder Treatment - Finviz

Feb 07, 2026

WAVE Life Sciences (NASDAQ:WVE) Downgraded by Wall Street Zen to "Sell" - MarketBeat

Feb 07, 2026

Feb 06, 2026

Wave Life Sciences receives back rights to AATD therapy from GSK - MSN

Feb 06, 2026

13 Best Revenue Growth Stocks to Buy Right Now - Insider Monkey

Feb 06, 2026

Feb 05, 2026

WAVE Life Sciences (NASDAQ:WVE) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat

Feb 05, 2026

WAVE Life Sciences (NASDAQ:WVE) Now Covered by Bank of America - MarketBeat

Feb 05, 2026

WVE Sees Analyst Rating Boost with Raised Price Target | WVE Stock News - GuruFocus

Feb 05, 2026

Assessing Wave Life Sciences (WVE) Valuation After Regaining Global Rights To WVE-006 From GSK - simplywall.st

Feb 05, 2026

Feb 04, 2026

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Wave Life Sciences (WVE) and Arcellx Inc (ACLX) - The Globe and Mail

Feb 04, 2026

Feb 03, 2026